Revision history of "DEVELOPMENT OF A NEW QUARTERLY RISPERIDONE FORMULATION" (Q3178153)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 10:5010:50, 9 October 2024DG Regio talk contribs 45,810 bytes +1 Set a claim value: summary (P836): O objectivo do projecto é desenvolver uma formulação de Risperidona Quarterly ISM com o grau adequado de funcionalidade e elevada viabilidade para o seu futuro fabrico que permita oferecer um produto de qualidade como alternativa às formulações de depósito de risperidona disponíveis até agora, bem como à já desenvolvida com esta tecnologia, mas com uma libertação prolongada de 3 vezes mais do que as actualmente disponíveis.

22 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 04:3404:34, 18 August 2022DG Regio talk contribs 43,463 bytes +27,565 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 18:5618:56, 12 October 2021DG Regio talk contribs 10,219 bytes +1,251 Created claim: summary (P836): The aim of the project is to develop a formulation of Risperidone Quarterly ISM with the appropriate degree of functionality and high feasibility for its future manufacture that allows to offer a quality product as an alternative to the depot formulations of risperidone available so far, as well as to the one already developed with this technology, but with a prolonged release of 3 times longer than those currently available., translated_summary
  • curprev 18:5618:56, 12 October 2021DG Regio talk contribs 8,968 bytes −1,251 Removed claim: summary (P836): The aim of the project is to develop a formulation of Risperidone Quarterly ISM with the appropriate degree of functionality and high feasibility for its future manufacture that allows to offer a quality product as an alternative to the depot formulations of risperidone available so far, as well as to the one already developed with this technology, but with a prolonged release of 3 times longer than those currently available., remove_old_engli...
  • curprev 18:5518:55, 12 October 2021DG Regio talk contribs 10,219 bytes +113 Changed label, description and/or aliases in en: translated_label
  • curprev 18:5518:55, 12 October 2021DG Regio talk contribs 10,106 bytes +1,251 Created claim: summary (P836): The aim of the project is to develop a formulation of Risperidone Quarterly ISM with the appropriate degree of functionality and high feasibility for its future manufacture that allows to offer a quality product as an alternative to the depot formulations of risperidone available so far, as well as to the one already developed with this technology, but with a prolonged release of 3 times longer than those currently available., translated_summary

10 October 2021

9 October 2021

8 October 2021